JPS6129743B2 - - Google Patents
Info
- Publication number
- JPS6129743B2 JPS6129743B2 JP55166610A JP16661080A JPS6129743B2 JP S6129743 B2 JPS6129743 B2 JP S6129743B2 JP 55166610 A JP55166610 A JP 55166610A JP 16661080 A JP16661080 A JP 16661080A JP S6129743 B2 JPS6129743 B2 JP S6129743B2
- Authority
- JP
- Japan
- Prior art keywords
- injection
- container
- discharge port
- blood
- welded
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 238000002347 injection Methods 0.000 claims description 33
- 239000007924 injection Substances 0.000 claims description 33
- 239000008280 blood Substances 0.000 claims description 20
- 210000004369 blood Anatomy 0.000 claims description 20
- 239000003814 drug Substances 0.000 claims description 16
- 239000000243 solution Substances 0.000 claims description 16
- 229940079593 drug Drugs 0.000 claims description 15
- 239000004800 polyvinyl chloride Substances 0.000 claims description 10
- 229920000915 polyvinyl chloride Polymers 0.000 claims description 10
- 229920005989 resin Polymers 0.000 claims description 7
- 239000011347 resin Substances 0.000 claims description 7
- BZHJMEDXRYGGRV-UHFFFAOYSA-N Vinyl chloride Chemical compound ClC=C BZHJMEDXRYGGRV-UHFFFAOYSA-N 0.000 claims description 5
- 238000004132 cross linking Methods 0.000 claims description 3
- 238000007789 sealing Methods 0.000 description 10
- 239000000463 material Substances 0.000 description 8
- 239000012778 molding material Substances 0.000 description 7
- 239000005060 rubber Substances 0.000 description 6
- 238000000034 method Methods 0.000 description 4
- 238000011109 contamination Methods 0.000 description 3
- 239000000428 dust Substances 0.000 description 3
- 238000005538 encapsulation Methods 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 244000005700 microbiome Species 0.000 description 3
- 238000003466 welding Methods 0.000 description 3
- 238000001746 injection moulding Methods 0.000 description 2
- 238000000465 moulding Methods 0.000 description 2
- 229920003023 plastic Polymers 0.000 description 2
- 239000004033 plastic Substances 0.000 description 2
- 238000006116 polymerization reaction Methods 0.000 description 2
- 239000002904 solvent Substances 0.000 description 2
- 229920005992 thermoplastic resin Polymers 0.000 description 2
- 239000000853 adhesive Substances 0.000 description 1
- 230000001070 adhesive effect Effects 0.000 description 1
- 230000000903 blocking effect Effects 0.000 description 1
- 238000005520 cutting process Methods 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 238000007599 discharging Methods 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 239000010408 film Substances 0.000 description 1
- 238000001802 infusion Methods 0.000 description 1
- 238000003780 insertion Methods 0.000 description 1
- 230000037431 insertion Effects 0.000 description 1
- 238000005304 joining Methods 0.000 description 1
- 239000008155 medical solution Substances 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 239000002985 plastic film Substances 0.000 description 1
- 229920000728 polyester Polymers 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
Description
【発明の詳細な説明】
本発明は軟質塩化ビニル樹脂等の軟質熱可塑性
樹脂シート又はフイルムよりなる薬液又は血液容
器に関するものであつて、詳しくは該容器の注
入・排出口を無菌的あるいは、無塵的状態に保持
するための被包部を有する薬液又は血液の採取、
保存あるいは移注用容器に関するものである。DETAILED DESCRIPTION OF THE INVENTION The present invention relates to a drug solution or blood container made of a soft thermoplastic resin sheet or film such as soft vinyl chloride resin. Collection of medicinal solutions or blood that has an encapsulation part to keep it in a dusty state;
Contains containers for storage or transfer.
一般に薬液又は血液容器においては、その注
入・排出口を使用の直前まで無菌もしくは無塵状
態に保つために、プラスチツクシートやフイル
ム、あるいはプラスチツクチユーブや成形品等で
被包することが通例となつてきている。 In general, it has become common practice for medical solution or blood containers to be covered with plastic sheets, films, plastic tubes, molded products, etc. in order to keep the injection and discharge ports sterile or dust-free until just before use. ing.
例えば、特開昭53−31390号公報においては、
チユーブの一端を溶閉し、注入・排出口に被せた
ものであり、実公昭50−19747号公報において
は、脆弱線を設けた射出成形等による被包体を溶
剤等の接着剤を用いて、注入・排出口に接着した
ものである。また実公昭52−42639号公報におい
ては、予じめ開封のためのフラツプを形成するた
めに、シート状成形品を被包体シートに熱接着し
た上、注入・排出口を被包したものである。 For example, in Japanese Patent Application Laid-open No. 53-31390,
One end of the tube is melted and placed over the injection/discharge port, and in Japanese Utility Model Publication No. 19747, an injection molded envelope with a line of weakness is formed using an adhesive such as a solvent. , which is glued to the inlet/outlet. Furthermore, in Japanese Utility Model Publication No. 52-42639, in order to form a flap for opening in advance, a sheet-shaped molded product is thermally bonded to an envelope sheet, and then the injection and discharge ports are covered. be.
上記の例に示すように、注入・排出口とその被
包は別個の部品よりなり、挿着、溶剤接着、熱接
着等により接合されている。かかる場合、部品の
製造工程と組立て接合工程がともに増えるため
に、該薬液又は血液容器の製造コストが増加する
ことに加えて、該容器において最も重大な欠陥で
ある微生物および塵埃による汚染の機会が増大す
る。 As shown in the above example, the inlet/outlet and its encapsulation are separate parts that are joined by insertion, solvent bonding, thermal bonding, or the like. In such a case, the manufacturing cost of the drug solution or blood container increases due to the increase in both the manufacturing process and the assembly and joining process of the parts, and the opportunity for contamination with microorganisms and dust, which is the most serious defect in the container, increases. increase
本発明の目的は、かかる現状に鑑みて該容器の
製造工程を簡略化し、微生物および塵埃による汚
染の機会を減少せしめ得る薬液又は血液容器を提
供せんとするものである。 In view of the current situation, an object of the present invention is to provide a drug solution or blood container that can simplify the manufacturing process of the container and reduce the chance of contamination by microorganisms and dust.
即ち軟質塩化ビニル系樹脂のシート又はフイル
ムよりなる薬液又は血液容器であつて、その注
入・排出口を構成する中空筒状物が袋体と熱シー
ル可能な架橋度2〜50%の部分架橋ポリ塩化ビニ
ル樹脂よりなつており、該中空筒状物が容器内容
物と外気を遮断する隔膜を有しており、その一端
は容器本体と溶着されており、他端は該中空筒状
物を容易に溶着封止可能なように薄肉化し、溶着
封止した部分にノツチ状切れこみ又は脆弱化部を
設けたことを特徴とする薬液又は血液容器であ
る。 In other words, it is a drug solution or blood container made of a sheet or film of a soft vinyl chloride resin, and the hollow cylindrical object constituting the injection/discharge port is made of a partially cross-linked polyester having a degree of cross-linking of 2 to 50% that can be heat-sealed to the bag body. The hollow cylindrical body is made of vinyl chloride resin, and has a diaphragm that blocks the contents of the container from the outside air, one end of which is welded to the main body of the container, and the other end that allows the hollow cylindrical body to be easily connected to the outside air. This container is characterized by having a thin wall so that it can be welded and sealed, and a notch-like cut or weakened part is provided in the welded and sealed part.
第1図、第2図において、軟質塩化ビニル系樹
脂等の軟質熱可塑性樹脂シート又はフイルムによ
りなる薬液又は血液容器は、一般に1ケ所ないし
数ケ所の容器内容物の注入又は排出口2を有し、
該注入・排出口2は容器内容物と外気を遮断する
ための隔膜6を備え、溶着部5において本体容器
1と接合されている。該注入・排出口2に注射針
又はプラスチツク針等を穿刺接合するに際して、
隔膜6を含む注入・排出口2の外気側の接合部の
少くとも内面は、本体容器1の内面と同様に無菌
および無塵状態に保持されていなければならな
い。このため別に用意したシート又は押出チユー
ブ若しくは射出成形品よりなる被包体3aにより
注入・排出口2を被包することが行なわれてい
る。 In FIGS. 1 and 2, a drug solution or blood container made of a sheet or film of a soft thermoplastic resin such as a soft vinyl chloride resin generally has one or several ports 2 for injecting or discharging the contents of the container. ,
The injection/discharge port 2 is provided with a diaphragm 6 for blocking the contents of the container from outside air, and is joined to the main container 1 at a welded portion 5. When puncturing a syringe needle, plastic needle, etc. to the injection/discharge port 2,
At least the inner surface of the joint on the outside air side of the inlet/outlet port 2, including the diaphragm 6, must be kept sterile and dust-free like the inner surface of the main container 1. For this reason, the injection/discharge port 2 is covered with a separately prepared covering body 3a made of a sheet, an extruded tube, or an injection molded product.
本発明においては、第3図−1,2,3に例示
する如く、射出成形等により注入・排出口2とそ
の被包体3bを一体の中空筒状物として成形し、
一端を本体容器1と溶着部5で接合した後、他端
を溶着封止することにより、該注入・排出口を清
浄に保持しうる薬液又は血液容器を得ることを基
本的な特徴とする。 In the present invention, as illustrated in FIGS. 3-1, 2, and 3, the injection/discharge port 2 and its envelope 3b are molded as an integral hollow cylindrical body by injection molding or the like,
The basic feature is that after one end is joined to the main container 1 at the welding part 5, the other end is welded and sealed to obtain a drug solution or blood container that can keep the injection/discharge port clean.
被包体3はヒートシール、超音波シール、高周
波シール等による溶着封止を容易にするために、
薄肉に成形することが好ましい。一般に注入・排
出口2の肉厚は材質の硬度によるが、0.5〜3mm
が好ましく、これに対する被包体3bの肉厚は、
該注入・排出口の肉厚の10〜80%の範囲で0.3〜
1.5mmが好ましい。さらに溶封を容易にするため
に、切り込み7を設けてもよい。また第3図−3
に例示する如く、注入・排出口2の途中より被包
体3bを形成することにより、注入・排出口の穿
刺接合端の外面をも清浄に保持することができ
る。 In order to facilitate welding and sealing by heat sealing, ultrasonic sealing, high frequency sealing, etc., the envelope 3 is
It is preferable to mold it into a thin wall. In general, the wall thickness of the injection/discharge port 2 depends on the hardness of the material, but is 0.5 to 3 mm.
is preferable, and the thickness of the envelope 3b with respect to this is,
0.3 to 10% to 80% of the wall thickness of the injection/discharge port
1.5mm is preferred. Furthermore, in order to facilitate melt sealing, a notch 7 may be provided. Also, Figure 3-3
By forming the envelope 3b from the middle of the injection/discharge port 2, as illustrated in FIG.
当該被包体3bは鋏等を用いずに容易に開封で
きることが好ましく、本発明者らは本体容器1と
接着可能で引裂性を付与した成形材料又は成形方
法、若しくは引裂性を付与した形状を用いること
により、被包体3bを容易に開封又は除去しうる
注入・排出口2を有する薬液又は血液容器を得る
ことができた。以下更に種々の実施例に従つて詳
述する。 It is preferable that the envelope 3b can be easily opened without using scissors or the like, and the present inventors have developed a molding material or molding method that can be bonded to the main container 1 and that has imparted tearability, or a shape that has imparted tearability. By using the present invention, it was possible to obtain a liquid medicine or blood container having an injection/discharge port 2 from which the envelope 3b could be easily opened or removed. Below, various examples will be further explained in detail.
実施例 1
第4図−1,2において、2〜50%の架橋度を
有する部分架橋ポリ塩化ビニルよりなる軟質ポリ
塩化ビニル成形材料を用いて、注入・排出口2と
被包体3bとを第3図−1,2に示す如く一体成
形し、本体容器1と溶着後、封止部4を形成し、
注入・排出口2を被包した。封止部4には、ノツ
チ状切れこみ8を設け、開口又は切断開始部とし
た。Example 1 In Figures 4-1 and 2, the injection/discharge port 2 and the envelope 3b were formed using a soft polyvinyl chloride molding material made of partially crosslinked polyvinyl chloride having a degree of crosslinking of 2 to 50%. As shown in FIG. 3-1 and 2, after integrally molding and welding to the main container 1, the sealing part 4 is formed,
The injection/discharge port 2 was encapsulated. The sealing part 4 was provided with a notch-like cut 8, which served as an opening or a cutting start part.
部分架橋ポリ塩化ビニルよりなる成形材料は引
裂強度が低く、かつ樹脂の流れ方向に配向しやす
い特性を有するために、容易に引裂くことがで
き、その方向性も安定しているため、開封性の極
めてすぐれた注入・排出口の被包体を有する血液
又は薬液容器を得ることができた。 Molding materials made of partially cross-linked polyvinyl chloride have low tear strength and are easily oriented in the flow direction of the resin, so they can be easily torn and their orientation is stable, making them easy to open. It was possible to obtain a blood or drug solution container having an extremely excellent injection/discharge port encapsulation.
実施例 2
第5図において、注入・排出口2の材質Aに平
均重合度800から1500のポリ塩化ビニルよりなる
軟質ポリ塩化ビニル成形材料を用い、被包体3b
側の材質Bに平均重合度2000から3000のポリ塩化
ビニルよりなる軟質ポリ塩化ビニル成形材料を用
いて、射出成形により注入・排出口2と被包体3
bとを一体に成形し、本体容器1と溶着した後、
他端を溶封し、両材料A,Bの境界部より開封容
易な注入・排出口の被包体を有する血液又は薬液
容器を得ることができた。Example 2 In FIG. 5, a soft polyvinyl chloride molding material made of polyvinyl chloride with an average degree of polymerization of 800 to 1500 is used as the material A of the injection/discharge port 2, and the encapsulating body 3b
Using a soft polyvinyl chloride molding material made of polyvinyl chloride with an average degree of polymerization of 2000 to 3000 as the side material B, the injection/discharge port 2 and the encapsulating body 3 are formed by injection molding.
b are integrally molded and welded to the main container 1,
By melt-sealing the other end, it was possible to obtain a blood or drug solution container having an envelope with an injection/discharge port that could be easily opened from the boundary between the two materials A and B.
同様に材質Bとして、実施例1に記載の部分架
橋ポリ塩化ビニル成形材料を用いて同等の効果を
得ることができた。 Similarly, when the partially crosslinked polyvinyl chloride molding material described in Example 1 was used as material B, the same effect could be obtained.
また本実施例において、材質Aと材質Bを入れ
かえてもよい。 Further, in this embodiment, material A and material B may be replaced.
実施例3及び実施例4においても注入・排出口
の材質として、実施例1に記載の部分架橋ポリ塩
化ビニル成形材料を使用した。 In Examples 3 and 4 as well, the partially crosslinked polyvinyl chloride molding material described in Example 1 was used as the material for the injection and discharge ports.
実施例 3
第6図において、薬液又は血液容器の注入・排
出口2とその被包体3bの間に薄肉の脆弱化線9
を設けて一体成形し、該脆弱化線9を開封線とす
る。開封に際しては、第6図−1においては、封
止部4付近をもつて被包体3bをねじ切り、ある
いは折り取ることができた。Example 3 In FIG. 6, a thin weakened line 9 is formed between the injection/discharge port 2 of the drug solution or blood container and its envelope 3b.
is provided and integrally molded, and the weakened line 9 is used as an opening line. When unsealing, as shown in FIG. 6-1, the envelope 3b could be threaded or broken off near the sealing part 4.
第6図−2においては、脆弱化線9を含めて封
止部4を形成し、ノツチ8により引裂き開封する
ことができた。第6図−3においては、脆弱化線
9の付近にフラツプ10を予め一体成形して設
け、該フラツプ10を引張ることにより容易に開
封することができた。 In FIG. 6-2, the sealing portion 4 was formed including the line of weakness 9, and the seal could be torn open using the notch 8. In FIG. 6-3, a flap 10 was previously integrally molded near the line of weakness 9, and the seal could be easily opened by pulling the flap 10.
実施例 4
薬液又は血液容器において、その注入・排出口
に注射針又は輸液セツト、採血セツト、輸血セツ
ト等の針を穿刺接合する場合にゴム栓を必要とす
る場合がある。Embodiment 4 A rubber stopper may be required when a syringe needle, an infusion set, a blood collection set, a blood transfusion set, etc., is punctured and connected to the injection/discharge port of a drug solution or blood container.
本実施例では、第7図においてゴム栓11を注
入・排出口2の中に封入、一体成形し、該ゴム栓
と内容液が接液しないように隔膜6を形成し、脱
落を防ぐためにゴム栓11を包囲するような突起
12を形成せしめ、注入・排出口2とその被包体
3bは一体に成形してなる。 In this embodiment, as shown in FIG. 7, a rubber stopper 11 is sealed and integrally molded inside the injection/discharge port 2, and a diaphragm 6 is formed to prevent the rubber stopper from coming into contact with the liquid inside. A protrusion 12 is formed to surround the stopper 11, and the injection/discharge port 2 and its envelope 3b are integrally molded.
これによつてゴム栓11から内容液に対するゴ
ム片の混入を防止し、ゴムとの接液による異物粒
子の増大を防ぐことができ、かつゴム栓11を有
する注入・排出口2がその被包体を含めて、一回
の工程で一体化成形されているため、微生物ある
いは塵埃による汚染の機会を最少限にすることが
できる。開封性の付与は、前述の実施例1〜3の
いずれの方法を用いても行なうことができる。 This prevents rubber pieces from entering the liquid from the rubber stopper 11 and prevents foreign particles from increasing due to contact with the rubber. Since everything including the body is integrally molded in a single process, chances of contamination by microorganisms or dust can be minimized. The imparting of unsealability can be achieved using any of the methods described in Examples 1 to 3 described above.
第1図は従来より公知の薬液・血液容器の一
例、第2図は従来より公知の薬液・血液容器の注
入・排出口付近の断面の一例、第3図−1は本発
明による薬液・血液容器の注入・排出口付近の断
面の一例、2,3は他の一例、第4図−1,2は
本発明の実施例1における注入・排出口の一例、
第5図は実施例2における注入・排出口の一例、
第6図−1,2,3は実施例3における注入・排
出口の一例、第7図は実施例4における注入・排
出口の一例である。
FIG. 1 is an example of a conventionally known drug solution/blood container, FIG. 2 is an example of a cross section near the injection/discharge port of a conventionally known drug solution/blood container, and FIG. 3-1 is an example of a drug solution/blood container according to the present invention. An example of a cross section near the injection/discharge port of the container, 2 and 3 are other examples, and Fig. 4-1 and 2 are examples of the injection/discharge port in Embodiment 1 of the present invention.
FIG. 5 is an example of the injection/discharge port in Embodiment 2,
6-1, 2, and 3 are examples of the injection/discharge ports in the third embodiment, and FIG. 7 is an example of the injection/discharge ports in the fourth embodiment.
Claims (1)
よりなる薬液又は血液容器であつて、その注入・
排出口を構成する中空筒状物が袋体と熱シール可
能な架橋度2〜50%の部分架橋ポリ塩化ビニル樹
脂よりなつており、該中空筒状物が容器内容物と
外気を遮断する隔膜を有しており、その一端は容
器本体と溶着されており、他端は該中空筒状物を
容易に溶着封止可能なように薄肉化し、溶着封止
した部分にノツチ状の切れこみ又は脆弱化部を設
けたことを特徴とする薬液又は血液容器。1 Containers for drug solutions or blood made of sheets or films of soft vinyl chloride resin, which are used for injection and
A hollow cylindrical body constituting the outlet is made of a partially crosslinked polyvinyl chloride resin with a crosslinking degree of 2 to 50% that can be heat-sealed to the bag body, and the hollow cylindrical body is a diaphragm that blocks the contents of the container from outside air. One end is welded to the container body, and the other end is thinned so that the hollow cylindrical object can be easily welded and sealed, and a notch-shaped cut or a notch is formed in the welded and sealed part. A drug solution or blood container characterized by having a weakened portion.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP55166610A JPS5793062A (en) | 1980-11-28 | 1980-11-28 | Drug liquid or blood container |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP55166610A JPS5793062A (en) | 1980-11-28 | 1980-11-28 | Drug liquid or blood container |
Publications (2)
Publication Number | Publication Date |
---|---|
JPS5793062A JPS5793062A (en) | 1982-06-09 |
JPS6129743B2 true JPS6129743B2 (en) | 1986-07-09 |
Family
ID=15834490
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP55166610A Granted JPS5793062A (en) | 1980-11-28 | 1980-11-28 | Drug liquid or blood container |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPS5793062A (en) |
-
1980
- 1980-11-28 JP JP55166610A patent/JPS5793062A/en active Granted
Also Published As
Publication number | Publication date |
---|---|
JPS5793062A (en) | 1982-06-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP3637495B2 (en) | Medical container port | |
US4558792A (en) | Container such as a nursing container, with flexible liner and access site and method of making said access site | |
US4657151A (en) | Container such as a nursing container, with flexible liner | |
US4516977A (en) | Storage bag | |
JP2001522280A (en) | Sterile connector | |
JPH1028720A (en) | Medical liquid injection apparatus | |
US2850422A (en) | Fluid container port structure attaching method | |
JP2001087350A (en) | Multi-chamber transfunction container and method of manufacturing the same | |
JPH0113859B2 (en) | ||
AU771466B2 (en) | Membrane port for a container | |
JPH03667A (en) | Package for storing medical vessel | |
JP2614428B2 (en) | Drip container | |
JPS6129743B2 (en) | ||
JP4675502B2 (en) | Liquid storage bag | |
JPH0824315A (en) | Bag made of plastic for medical treatment | |
JPH0448192Y2 (en) | ||
JP2882839B2 (en) | Container with contents for mixing | |
JPH0531153A (en) | Transfusion container | |
JPH10151172A (en) | Infusion container for instillation | |
JPH0613708Y2 (en) | Infusion container | |
JP2840626B2 (en) | Bag-shaped container and method for producing the same | |
JPH0144339B2 (en) | ||
JPH0546460Y2 (en) | ||
JPH1148325A (en) | Mold for blow-molded vessel and medical vessel manufactured by mold | |
WO1985004572A1 (en) | Container such as a nursing container, with flexible liner and access site and method of making same |